RESEARCHER PROFILE

George Ntaios

← Back to Aristotle University of Thessaloniki

G

Aristotle University of Thessaloniki

Acute Ischemic Stroke ManagementAtrial Fibrillation Management and OutcomesCerebrovascular and Carotid Artery DiseasesCardiovascular and Diving-Related ComplicationsIntracerebral and Subarachnoid Hemorrhage Research

George Ntaios works in Acute Ischemic Stroke Management, Atrial Fibrillation Management and Outcomes, Cerebrovascular and Carotid Artery Diseases, Cardiovascular and Diving-Related Complications, Intracerebral and Subarachnoid Hemorrhage Research. Recorded institutional associations include University of Thessaly, Aristotle University of Thessaloniki, AHEPA University Hospital.

455Publications
31,138Citations
66H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    2024 · 5,023 citations
  2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    2024 · 2,836 citations
  3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    2024 · 2,820 citations
  4. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    2024 · 2,019 citations
  5. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    2024 · 1,699 citations
  6. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

    2018 · 1,028 citations
  7. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

    2024 · 1,025 citations
  8. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

    2024 · 1,025 citations
  9. Embolic Stroke of Undetermined Source

    2017 · 553 citations
  10. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

    2020 · 452 citations
  11. Association Between Obesity and Mortality After Acute First-Ever Stroke

    2010 · 324 citations
  12. An integer-based score to predict functional outcome in acute ischemic stroke

    2012 · 301 citations
  13. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke

    2020 · 282 citations
  14. Embolic Stroke of Undetermined Source

    2020 · 247 citations
  15. Searching for Atrial Fibrillation Poststroke

    2019 · 246 citations
  16. The Acute STroke Registry and Analysis of Lausanne (ASTRAL)

    2010 · 237 citations
  17. Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

    2023 · 230 citations
  18. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

    2017 · 214 citations
  19. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation

    2019 · 207 citations
  20. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

    2017 · 192 citations
  21. CHADS 2 , CHA 2 DS 2 -VASc, and long-term stroke outcome in patients without atrial fibrillation

    2013 · 188 citations
  22. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    2018 · 180 citations
  23. Embolic Strokes of Undetermined Source in the Athens Stroke Registry

    2014 · 178 citations
  24. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018

    2019 · 177 citations
  25. Maintaining stroke care in Europe during the COVID-19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation

    2020 · 158 citations

← Return to the university profile